0.5197
                                            Schlusskurs vom Vortag:
              $0.4654
            Offen:
              $0.454
            24-Stunden-Volumen:
                23.16M
            Relative Volume:
              6.04
            Marktkapitalisierung:
                $25.72M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-29.77M
            KGV:
              -0.034
            EPS:
                -15.2954
            Netto-Cashflow:
                $-24.23M
            1W Leistung:
              +4.80%
            1M Leistung:
              +12.56%
            6M Leistung:
                -49.54%
            1J Leistung:
              -78.79%
            Moleculin Biotech Inc Stock (MBRX) Company Profile
Firmenname
                  
                      Moleculin Biotech Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      713-300-5160
                    
                Adresse
                  
                      5300 MEMORIAL DRIVE, HOUSTON, TX
                    
                Vergleichen Sie MBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                MBRX
                            
                             
                        Moleculin Biotech Inc 
                           | 
                    0.5197 | 23.04M | 0 | -29.77M | -24.23M | -15.30 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-09 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2025-02-12 | Herabstufung | Maxim Group | Buy → Hold | 
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform | 
Moleculin Biotech Inc Aktie (MBRX) Neueste Nachrichten
Real time scanner hits for Moleculin Biotech Inc. explainedQuarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Can Moleculin Biotech Inc. stock continue upward trend2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Can machine learning forecast Moleculin Biotech Inc. recovery2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Can Moleculin Biotech Inc. stock deliver surprise earnings beatJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
How sentiment analysis helps forecast Moleculin Biotech Inc.July 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Market reaction to Moleculin Biotech Inc.’s recent newsInsider Buying & Comprehensive Market Scan Insights - newser.com
Is it time to cut losses on Moleculin Biotech Inc.Insider Buying & Technical Confirmation Trade Alerts - newser.com
Will Moleculin Biotech Inc. (MOL) stock top growth indexes2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Relative strength of Moleculin Biotech Inc. in sector analysisTrade Ideas & AI Optimized Trading Strategy Guides - newser.com
Is Moleculin Biotech Inc. stock attractive after correctionTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
How Moleculin Biotech Inc. stock benefits from global expansion2025 Dividend Review & Community Driven Trade Alerts - newser.com
Why Moleculin Biotech Inc. stock is rated strong buy2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Can Moleculin Biotech Inc. (MOL) stock stage a strong rebound this quarter2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Why analysts maintain buy rating on Moleculin Biotech Inc. (MOL) stockWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Will Moleculin Biotech Inc. continue its uptrendMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-02 06:40:39 - newser.com
What margin trends mean for Moleculin Biotech Inc. stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
How Moleculin Biotech Inc. stock reacts to inflationary pressuresStock Surge & Expert Curated Trade Setups - newser.com
Published on: 2025-11-02 01:09:40 - newser.com
Is Moleculin Biotech Inc. meeting your algorithmic filter criteria2025 Momentum Check & Smart Money Movement Tracker - newser.com
How to use a screener to detect Moleculin Biotech Inc. breakoutsJuly 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
Predicting Moleculin Biotech Inc. trend using moving averages2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Will Moleculin Biotech Inc. stock go up soonJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):